Vasant Narasimhan
Vasant Narasimhan is the chief executive of Novartis, a leading global healthcare company based in Switzerland. He has been with Novartis since 2005, and he became CEO in 2018, where he has focused on advancing the company's research and development efforts while addressing the challenges of the pharmaceutical industry. His leadership comes during a time of significant transformation in healthcare, emphasizing the importance of innovation and patient-centered care.
Not in the pool (under ¢1).
Recent news mentions
Vasant Narasimhan is the CEO of Novartis and was present during Trump's speech on drug prices.
Droht eine Verknüpfung mit den Medikamentenpreisen?
Switzerland· 2026-01-17
Vasant Narasimhan is depicted alongside Sergio Ermotti in a protest image shared by the Juso.
Juso bezeichnet Israels Präsident Herzog als KriegsverbrecherSwitzerland· 2026-01-16
Vasant Narasimhan is the CEO of Novartis, whose strategy is being discussed in the context of the company's performance.
Was The Market vom Börsenjahr 2026 erwartetSwitzerland· 2025-12-24
Vasant Narasimhan is the CEO of Novartis and has been with the company since 2005.
Der Novartis-Chef fordert höhere Preise für Medikamente in EuropaSwitzerland· 2025-09-20
Vasant Narasimhan is the CEO of Novartis and has been implementing a strategy of acquiring advanced drug candidates.
Warum Roche ins Stolpern gerät – und Novartis Vertrauen gewinntSwitzerland· 2025-09-01
Vasant Narasimhan is the CEO of Novartis who received a compensation of over 19 million francs for 2024.
Lohndeckel für UBS-Chefs dürfte im Parlament durchfallenSwitzerland· 2025-08-20
Vasant Narasimhan is the CEO of Novartis and has been noted for his positive surprises in financial presentations.
Warum die Börse Novartis trotz guter Zahlen nicht belohntSwitzerland· 2025-04-29
Vasant Narasimhan is the CEO of Novartis and has called for higher drug prices in Europe.
Helvetia-Baloise-Fusion: Grätscht Zurich noch dazwischen?Switzerland· 2025-04-25
Vasant Narasimhan is the current CEO of Novartis, whose past acquisition results have been mixed.
«Novartis hat noch viel Spielraum zur Steigerung der Margen»Switzerland· 2025-04-04
Vasant Narasimhan is the CEO of Novartis, a globally renowned innovative pharmaceutical company.
韩正会见外国企业负责人 --时政--人民网
China· 2025-03-25
Vasant Narasimhan is the CEO of Novartis, a globally renowned innovative pharmaceutical company.
韩正会见外国企业负责人--时政--人民网China· 2025-03-24
Vasant Narasimhan was paid a total of 19.2 million Swiss francs last year as the chief executive of Novartis.
UBS paid chief Sergio Ermotti €15.4m last year – The Irish Times
Ireland· 2025-03-17
